APAC Thrombectomy Devices Market

APAC Thrombectomy Devices Market Size (2022 to 2027)

The size of the Asia Pacific Thrombectomy Devices Market has been calculated at USD 0.27 billion in 2022. It is estimated to be growing at a CAGR of 7.5% and worth USD 0.39 billion by 2027.

Thrombectomy Devices involves removing thrombi using surgical procedures in emergency cases, which can result in blocked blood circulation. Thrombi are blood clots, but in general usage, it can refer to any substances that block the blood flow and lead to health issues. It is usually the last resort as a long-term hindrance of blood flow to organs can lead to necrosis.

Some Thrombectomy Devices procedures which are commonly performed are surgical embolectomy, balloon embolectomy, and aspiration embolectomy. A catheter is inserted into a blood vessel in a balloon embolectomy, which has an inflatable balloon at the tip. It is then inserted into a blood clot and inflated, and then the balloon is pulled out along with the clot. Some of the risks involved in the procedure are the chance of intimal lesions, giving rise to another thrombosis. Surgical embolectomy involves the removal of a clot by surgical incision into an artery. Aspiration embolectomy involves removing thrombus using suction instead of a balloon. It is regarded as a quick and effective way of removing thrombi in limb arteries.

The driving factors of the Asia-Pacific Thrombectomy Devices market are increasing demand for minimally invasive procedures, rising prevalence of cardiovascular diseases, growing sedentary lifestyle, technological innovations in the medical field, and growing geriatric population. Some of the setbacks involved in this market are difficulty using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases. 

This research report on the APAC Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:

By Type:

• Stent Retrievers
• Basket/Brush Retrievers
• Coil Retrievers
• Mechanical Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices

By Application:

• Peripheral Vascular Application
• Neurovascular Application
• Cardiovascular Application

By End Users: 

• Research Laboratories & Academic Institutes
• Ambulatory Surgical Centres
• Hospital Surgical Centres
• Others

By Disease: 

• Coronary Diseases
• Neural Diseases
• Peripheral Diseases

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, Asia-Pacific is the fastest-growing market globally, owing to factors like many patients, increased local manufacturing, growing distribution networks, and rising awareness among surgeons about the safety of new equipment. India is the fastest-growing region in Asia-Pacific. Factors such as increased incidence of a sedentary lifestyle, rising cardiovascular diseases, and technological advancements in the medical field are expected to drive the region's market growth.

Companies that are playing a leading role in the Asia Pacific Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).